COVID-19 Impact on Global Rivaroxaban Market Insights, Forecast to 2026

Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.

The global average price of Rivaroxaban is in the decreasing trend, from 5.62 USD/Unit in 2011 to 5.34 USD/Unit in 2015. With the situation of global economy, prices will be in slowly decreasing trend in the following five years.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Rivaroxaban 3900 market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Rivaroxaban 3900 industry.

Based on our recent survey, we have several different scenarios about the Rivaroxaban 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 6908.7 million in 2019. The market size of Rivaroxaban 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rivaroxaban market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rivaroxaban market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Rivaroxaban market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Sales and Pricing Analyses

Readers are provided with deeper sales analysis and pricing analysis for the global Rivaroxaban market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Rivaroxaban market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Rivaroxaban market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rivaroxaban market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rivaroxaban market.

    Bayer

    J&J

    ...

    2.5 mg

    10 mg

    15 mg

    20 mg

    Acute Coronary Syndrome (ACS)

    Venous Thromboembolism (VTE)

1.1 Rivaroxaban Product Introduction

1.2 Market Segments

1.3 Key Rivaroxaban Manufacturers Covered: Ranking by Revenue

1.4 Market by Type

1.4.1 Global Rivaroxaban Market Size Growth Rate by Type

1.4.2 2.5 mg

1.4.3 10 mg

1.4.4 15 mg

1.4.5 20 mg

1.5 Market by Application

1.5.1 Global Rivaroxaban Market Size Growth Rate by Application

1.5.2 Acute Coronary Syndrome (ACS)

1.5.3 Venous Thromboembolism (VTE)

1.6 Coronavirus Disease 2019 (Covid-19): Rivaroxaban Industry Impact

1.6.1 How the Covid-19 is Affecting the Rivaroxaban Industry

1.6.1.1 Rivaroxaban Business Impact Assessment - Covid-19

1.6.1.2 Supply Chain Challenges

1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products

1.6.2 Market Trends and Rivaroxaban Potential Opportunities in the COVID-19 Landscape

1.6.3 Measures / Proposal against Covid-19

1.6.3.1 Government Measures to Combat Covid-19 Impact

1.6.3.2 Proposal for Rivaroxaban Players to Combat Covid-19 Impact

1.7 Study Objectives

1.8 Years Considered

2.1 Global Rivaroxaban Market Size Estimates and Forecasts

2.1.1 Global Rivaroxaban Revenue 2015-2026

2.1.2 Global Rivaroxaban Sales 2015-2026

2.2 Rivaroxaban Market Size by Region: 2020 Versus 2026

2.2.1 Global Rivaroxaban Retrospective Market Scenario in Sales by Region: 2015-2020

2.2.2 Global Rivaroxaban Retrospective Market Scenario in Revenue by Region: 2015-2020

3.1 Rivaroxaban Sales by Manufacturers

3.1.1 Rivaroxaban Sales by Manufacturers (2015-2020)

3.1.2 Rivaroxaban Sales Market Share by Manufacturers (2015-2020)

3.2 Rivaroxaban Revenue by Manufacturers

3.2.1 Rivaroxaban Revenue by Manufacturers (2015-2020)

3.2.2 Rivaroxaban Revenue Share by Manufacturers (2015-2020)

3.2.3 Global Rivaroxaban Market Concentration Ratio (CR5 and HHI) (2015-2020)

3.2.4 Global Top 10 and Top 5 Companies by Rivaroxaban Revenue in 2019

3.2.5 Global Rivaroxaban Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Rivaroxaban Price by Manufacturers

3.4 Rivaroxaban Manufacturing Base Distribution, Product Types

3.4.1 Rivaroxaban Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Rivaroxaban Product Type

3.4.3 Date of International Manufacturers Enter into Rivaroxaban Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4.1 Global Rivaroxaban Market Size by Type (2015-2020)

4.1.1 Global Rivaroxaban Sales by Type (2015-2020)

4.1.2 Global Rivaroxaban Revenue by Type (2015-2020)

4.1.3 Rivaroxaban Average Selling Price (ASP) by Type (2015-2026)

4.2 Global Rivaroxaban Market Size Forecast by Type (2021-2026)

4.2.1 Global Rivaroxaban Sales Forecast by Type (2021-2026)

4.2.2 Global Rivaroxaban Revenue Forecast by Type (2021-2026)

4.2.3 Rivaroxaban Average Selling Price (ASP) Forecast by Type (2021-2026)

4.3 Global Rivaroxaban Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5.1 Global Rivaroxaban Market Size by Application (2015-2020)

5.1.1 Global Rivaroxaban Sales by Application (2015-2020)

5.1.2 Global Rivaroxaban Revenue by Application (2015-2020)

5.1.3 Rivaroxaban Price by Application (2015-2020)

5.2 Rivaroxaban Market Size Forecast by Application (2021-2026)

5.2.1 Global Rivaroxaban Sales Forecast by Application (2021-2026)

5.2.2 Global Rivaroxaban Revenue Forecast by Application (2021-2026)

5.2.3 Global Rivaroxaban Price Forecast by Application (2021-2026)

6.1 North America Rivaroxaban by Country

6.1.1 North America Rivaroxaban Sales by Country

6.1.2 North America Rivaroxaban Revenue by Country

6.1.3 U.S.

6.1.4 Canada

6.2 North America Rivaroxaban Market Facts & Figures by Type

6.3 North America Rivaroxaban Market Facts & Figures by Application

7.1 Europe Rivaroxaban by Country

7.1.1 Europe Rivaroxaban Sales by Country

7.1.2 Europe Rivaroxaban Revenue by Country

7.1.3 Germany

7.1.4 France

7.1.5 U.K.

7.1.6 Italy

7.1.7 Russia

7.2 Europe Rivaroxaban Market Facts & Figures by Type

7.3 Europe Rivaroxaban Market Facts & Figures by Application

8.1 Asia Pacific Rivaroxaban by Region

8.1.1 Asia Pacific Rivaroxaban Sales by Region

8.1.2 Asia Pacific Rivaroxaban Revenue by Region

8.1.3 China

8.1.4 Japan

8.1.5 South Korea

8.1.6 India

8.1.7 Australia

8.1.8 Taiwan

8.1.9 Indonesia

8.1.10 Thailand

8.1.11 Malaysia

8.1.12 Philippines

8.1.13 Vietnam

8.2 Asia Pacific Rivaroxaban Market Facts & Figures by Type

8.3 Asia Pacific Rivaroxaban Market Facts & Figures by Application

9.1 Latin America Rivaroxaban by Country

9.1.1 Latin America Rivaroxaban Sales by Country

9.1.2 Latin America Rivaroxaban Revenue by Country

9.1.3 Mexico

9.1.4 Brazil

9.1.5 Argentina

9.2 Central & South America Rivaroxaban Market Facts & Figures by Type

9.3 Central & South America Rivaroxaban Market Facts & Figures by Application

10.1 Middle East and Africa Rivaroxaban by Country

10.1.1 Middle East and Africa Rivaroxaban Sales by Country

10.1.2 Middle East and Africa Rivaroxaban Revenue by Country

10.1.3 Turkey

10.1.4 Saudi Arabia

10.1.5 UAE

10.2 Middle East and Africa Rivaroxaban Market Facts & Figures by Type

10.3 Middle East and Africa Rivaroxaban Market Facts & Figures by Application

11.1 Bayer

11.1.1 Bayer Corporation Information

11.1.2 Bayer Description, Business Overview and Total Revenue

11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)

11.1.4 Bayer Rivaroxaban Products Offered

11.1.5 Bayer Recent Development

11.2 J&J

11.2.1 J&J Corporation Information

11.2.2 J&J Description, Business Overview and Total Revenue

11.2.3 J&J Sales, Revenue and Gross Margin (2015-2020)

11.2.4 J&J Rivaroxaban Products Offered

11.2.5 J&J Recent Development

11.1 Bayer

11.1.1 Bayer Corporation Information

11.1.2 Bayer Description, Business Overview and Total Revenue

11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)

11.1.4 Bayer Rivaroxaban Products Offered

11.1.5 Bayer Recent Development

12.1 Rivaroxaban Market Estimates and Projections by Region

12.1.1 Global Rivaroxaban Sales Forecast by Regions 2021-2026

12.1.2 Global Rivaroxaban Revenue Forecast by Regions 2021-2026

12.2 North America Rivaroxaban Market Size Forecast (2021-2026)

12.2.1 North America: Rivaroxaban Sales Forecast (2021-2026)

12.2.2 North America: Rivaroxaban Revenue Forecast (2021-2026)

12.2.3 North America: Rivaroxaban Market Size Forecast by Country (2021-2026)

12.3 Europe Rivaroxaban Market Size Forecast (2021-2026)

12.3.1 Europe: Rivaroxaban Sales Forecast (2021-2026)

12.3.2 Europe: Rivaroxaban Revenue Forecast (2021-2026)

12.3.3 Europe: Rivaroxaban Market Size Forecast by Country (2021-2026)

12.4 Asia Pacific Rivaroxaban Market Size Forecast (2021-2026)

12.4.1 Asia Pacific: Rivaroxaban Sales Forecast (2021-2026)

12.4.2 Asia Pacific: Rivaroxaban Revenue Forecast (2021-2026)

12.4.3 Asia Pacific: Rivaroxaban Market Size Forecast by Region (2021-2026)

12.5 Latin America Rivaroxaban Market Size Forecast (2021-2026)

12.5.1 Latin America: Rivaroxaban Sales Forecast (2021-2026)

12.5.2 Latin America: Rivaroxaban Revenue Forecast (2021-2026)

12.5.3 Latin America: Rivaroxaban Market Size Forecast by Country (2021-2026)

12.6 Middle East and Africa Rivaroxaban Market Size Forecast (2021-2026)

12.6.1 Middle East and Africa: Rivaroxaban Sales Forecast (2021-2026)

12.6.2 Middle East and Africa: Rivaroxaban Revenue Forecast (2021-2026)

12.6.3 Middle East and Africa: Rivaroxaban Market Size Forecast by Country (2021-2026)

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Porter’s Five Forces Analysis

13.5 Primary Interviews with Key Rivaroxaban Players (Opinion Leaders)

14.1 Value Chain Analysis

14.2 Rivaroxaban Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

List of Tables

    Table 1. Rivaroxaban Market Segments

    Table 2. Ranking of Global Top Rivaroxaban Manufacturers by Revenue (US$ Million) in 2019

    Table 3. Global Rivaroxaban Market Size Growth Rate by Type 2020-2026 (M Units) & (US$ Million)

    Table 4. Major Manufacturers of 2.5 mg

    Table 5. Major Manufacturers of 10 mg

    Table 6. Major Manufacturers of 15 mg

    Table 7. Major Manufacturers of 20 mg

    Table 8. COVID-19 Impact Global Market: (Four Rivaroxaban Market Size Forecast Scenarios)

    Table 9. Opportunities and Trends for Rivaroxaban Players in the COVID-19 Landscape

    Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

    Table 11. Key Regions/Countries Measures against Covid-19 Impact

    Table 12. Proposal for Rivaroxaban Players to Combat Covid-19 Impact

    Table 13. Global Rivaroxaban Market Size Growth Rate by Application 2020-2026 (M Units)

    Table 14. Global Rivaroxaban Market Size by Region (M Units) & (US$ Million): 2020 VS 2026

    Table 15. Global Rivaroxaban Sales by Regions 2015-2020 (M Units)

    Table 16. Global Rivaroxaban Sales Market Share by Regions (2015-2020)

    Table 17. Global Rivaroxaban Revenue by Regions 2015-2020 (US$ Million)

    Table 18. Global Rivaroxaban Sales by Manufacturers (2015-2020) (M Units)

    Table 19. Global Rivaroxaban Sales Share by Manufacturers (2015-2020)

    Table 20. Global Rivaroxaban Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

    Table 21. Global Rivaroxaban by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rivaroxaban as of 2019)

    Table 22. Rivaroxaban Revenue by Manufacturers (2015-2020) (US$ Million)

    Table 23. Rivaroxaban Revenue Share by Manufacturers (2015-2020)

    Table 24. Key Manufacturers Rivaroxaban Price (2015-2020) (USD/Unit)

    Table 25. Rivaroxaban Manufacturers Manufacturing Base Distribution and Headquarters

    Table 26. Manufacturers Rivaroxaban Product Type

    Table 27. Date of International Manufacturers Enter into Rivaroxaban Market

    Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 29. Global Rivaroxaban Sales by Type (2015-2020) (M Units)

    Table 30. Global Rivaroxaban Sales Share by Type (2015-2020)

    Table 31. Global Rivaroxaban Revenue by Type (2015-2020) (US$ Million)

    Table 32. Global Rivaroxaban Revenue Share by Type (2015-2020)

    Table 33. Rivaroxaban Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)

    Table 34. Global Rivaroxaban Sales by Application (2015-2020) (M Units)

    Table 35. Global Rivaroxaban Sales Share by Application (2015-2020)

    Table 36. North America Rivaroxaban Sales by Country (2015-2020) (M Units)

    Table 37. North America Rivaroxaban Sales Market Share by Country (2015-2020)

    Table 38. North America Rivaroxaban Revenue by Country (2015-2020) (US$ Million)

    Table 39. North America Rivaroxaban Revenue Market Share by Country (2015-2020)

    Table 40. North America Rivaroxaban Sales by Type (2015-2020) (M Units)

    Table 41. North America Rivaroxaban Sales Market Share by Type (2015-2020)

    Table 42. North America Rivaroxaban Sales by Application (2015-2020) (M Units)

    Table 43. North America Rivaroxaban Sales Market Share by Application (2015-2020)

    Table 44. Europe Rivaroxaban Sales by Country (2015-2020) (M Units)

    Table 45. Europe Rivaroxaban Sales Market Share by Country (2015-2020)

    Table 46. Europe Rivaroxaban Revenue by Country (2015-2020) (US$ Million)

    Table 47. Europe Rivaroxaban Revenue Market Share by Country (2015-2020)

    Table 48. Europe Rivaroxaban Sales by Type (2015-2020) (M Units)

    Table 49. Europe Rivaroxaban Sales Market Share by Type (2015-2020)

    Table 50. Europe Rivaroxaban Sales by Application (2015-2020) (M Units)

    Table 51. Europe Rivaroxaban Sales Market Share by Application (2015-2020)

    Table 52. Asia Pacific Rivaroxaban Sales by Region (2015-2020) (M Units)

    Table 53. Asia Pacific Rivaroxaban Sales Market Share by Region (2015-2020)

    Table 54. Asia Pacific Rivaroxaban Revenue by Region (2015-2020) (US$ Million)

    Table 55. Asia Pacific Rivaroxaban Revenue Market Share by Region (2015-2020)

    Table 56. Asia Pacific Rivaroxaban Sales by Type (2015-2020) (M Units)

    Table 57. Asia Pacific Rivaroxaban Sales Market Share by Type (2015-2020)

    Table 58. Asia Pacific Rivaroxaban Sales by Application (2015-2020) (M Units)

    Table 59. Asia Pacific Rivaroxaban Sales Market Share by Application (2015-2020)

    Table 60. Latin America Rivaroxaban Sales by Country (2015-2020) (M Units)

    Table 61. Latin America Rivaroxaban Sales Market Share by Country (2015-2020)

    Table 62. Latin Americaa Rivaroxaban Revenue by Country (2015-2020) (US$ Million)

    Table 63. Latin America Rivaroxaban Revenue Market Share by Country (2015-2020)

    Table 64. Latin America Rivaroxaban Sales by Type (2015-2020) (M Units)

    Table 65. Latin America Rivaroxaban Sales Market Share by Type (2015-2020)

    Table 66. Latin America Rivaroxaban Sales by Application (2015-2020) (M Units)

    Table 67. Latin America Rivaroxaban Sales Market Share by Application (2015-2020)

    Table 68. Middle East and Africa Rivaroxaban Sales by Country (2015-2020) (M Units)

    Table 69. Middle East and Africa Rivaroxaban Sales Market Share by Country (2015-2020)

    Table 70. Middle East and Africa Rivaroxaban Revenue by Country (2015-2020) (US$ Million)

    Table 71. Middle East and Africa Rivaroxaban Revenue Market Share by Country (2015-2020)

    Table 72. Middle East and Africa Rivaroxaban Sales by Type (2015-2020) (M Units)

    Table 73. Middle East and Africa Rivaroxaban Sales Market Share by Type (2015-2020)

    Table 74. Middle East and Africa Rivaroxaban Sales by Application (2015-2020) (M Units)

    Table 75. Middle East and Africa Rivaroxaban Sales Market Share by Application (2015-2020)

    Table 76. Bayer Corporation Information

    Table 77. Bayer Description and Major Businesses

    Table 78. Bayer Rivaroxaban Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 79. Bayer Product

    Table 80. Bayer Recent Development

    Table 81. J&J Corporation Information

    Table 82. J&J Description and Major Businesses

    Table 83. J&J Rivaroxaban Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 84. J&J Product

    Table 85. J&J Recent Development

    Table 86. Global Rivaroxaban Sales Forecast by Regions (2021-2026) (M Units)

    Table 87. Global Rivaroxaban Sales Market Share Forecast by Regions (2021-2026)

    Table 88. Global Rivaroxaban Revenue Forecast by Regions (2021-2026) (US$ Million)

    Table 89. Global Rivaroxaban Revenue Market Share Forecast by Regions (2021-2026)

    Table 90. North America: Rivaroxaban Sales Forecast by Country (2021-2026) (M Units)

    Table 91. North America: Rivaroxaban Revenue Forecast by Country (2021-2026) (US$ Million)

    Table 92. Europe: Rivaroxaban Sales Forecast by Country (2021-2026) (M Units)

    Table 93. Europe: Rivaroxaban Revenue Forecast by Country (2021-2026) (US$ Million)

    Table 94. Asia Pacific: Rivaroxaban Sales Forecast by Region (2021-2026) (M Units)

    Table 95. Asia Pacific: Rivaroxaban Revenue Forecast by Region (2021-2026) (US$ Million)

    Table 96. Latin America: Rivaroxaban Sales Forecast by Country (2021-2026) (M Units)

    Table 97. Latin America: Rivaroxaban Revenue Forecast by Country (2021-2026) (US$ Million)

    Table 98. Middle East and Africa: Rivaroxaban Sales Forecast by Country (2021-2026) (M Units)

    Table 99. Middle East and Africa: Rivaroxaban Revenue Forecast by Country (2021-2026) (US$ Million)

    Table 100. Key Opportunities and Drivers: Impact Analysis (2021-2026)

    Table 101. Key Challenges

    Table 102. Market Risks

    Table 103. Main Points Interviewed from Key Rivaroxaban Players

    Table 104. Rivaroxaban Customers List

    Table 105. Rivaroxaban Distributors List

    Table 106. Research Programs/Design for This Report

    Table 107. Key Data Information from Secondary Sources

    Table 108. Key Data Information from Primary Sources

List of Figures

    Figure 1. Rivaroxaban Product Picture

    Figure 2. Global Rivaroxaban Sales Market Share by Type in 2020 & 2026

    Figure 3. 2.5 mg Product Picture

    Figure 4. 10 mg Product Picture

    Figure 5. 15 mg Product Picture

    Figure 6. 20 mg Product Picture

    Figure 7. Global Rivaroxaban Sales Market Share by Application in 2020 & 2026

    Figure 8. Acute Coronary Syndrome (ACS)

    Figure 9. Venous Thromboembolism (VTE)

    Figure 10. Rivaroxaban Report Years Considered

    Figure 11. Global Rivaroxaban Market Size 2015-2026 (US$ Million)

    Figure 12. Global Rivaroxaban Sales 2015-2026 (M Units)

    Figure 13. Global Rivaroxaban Market Size Market Share by Region: 2020 Versus 2026

    Figure 14. Global Rivaroxaban Sales Market Share by Region (2015-2020)

    Figure 15. Global Rivaroxaban Sales Market Share by Region in 2019

    Figure 16. Global Rivaroxaban Revenue Market Share by Region (2015-2020)

    Figure 17. Global Rivaroxaban Revenue Market Share by Region in 2019

    Figure 18. Global Rivaroxaban Sales Share by Manufacturer in 2019

    Figure 19. The Top 10 and 5 Players Market Share by Rivaroxaban Revenue in 2019

    Figure 20. Rivaroxaban Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

    Figure 21. Global Rivaroxaban Sales Market Share by Type (2015-2020)

    Figure 22. Global Rivaroxaban Sales Market Share by Type in 2019

    Figure 23. Global Rivaroxaban Revenue Market Share by Type (2015-2020)

    Figure 24. Global Rivaroxaban Revenue Market Share by Type in 2019

    Figure 25. Global Rivaroxaban Market Share by Price Range (2015-2020)

    Figure 26. Global Rivaroxaban Sales Market Share by Application (2015-2020)

    Figure 27. Global Rivaroxaban Sales Market Share by Application in 2019

    Figure 28. Global Rivaroxaban Revenue Market Share by Application (2015-2020)

    Figure 29. Global Rivaroxaban Revenue Market Share by Application in 2019

    Figure 30. North America Rivaroxaban Sales Growth Rate 2015-2020 (M Units)

    Figure 31. North America Rivaroxaban Revenue Growth Rate 2015-2020 (US$ Million)

    Figure 32. North America Rivaroxaban Sales Market Share by Country in 2019

    Figure 33. North America Rivaroxaban Revenue Market Share by Country in 2019

    Figure 34. U.S. Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 35. U.S. Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 36. Canada Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 37. Canada Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 38. North America Rivaroxaban Market Share by Type in 2019

    Figure 39. North America Rivaroxaban Market Share by Application in 2019

    Figure 40. Europe Rivaroxaban Sales Growth Rate 2015-2020 (M Units)

    Figure 41. Europe Rivaroxaban Revenue Growth Rate 2015-2020 (US$ Million)

    Figure 42. Europe Rivaroxaban Sales Market Share by Country in 2019

    Figure 43. Europe Rivaroxaban Revenue Market Share by Country in 2019

    Figure 44. Germany Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 45. Germany Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 46. France Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 47. France Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 48. U.K. Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 49. U.K. Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 50. Italy Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 51. Italy Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 52. Russia Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 53. Russia Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 54. Europe Rivaroxaban Market Share by Type in 2019

    Figure 55. Europe Rivaroxaban Market Share by Application in 2019

    Figure 56. Asia Pacific Rivaroxaban Sales Growth Rate 2015-2020 (M Units)

    Figure 57. Asia Pacific Rivaroxaban Revenue Growth Rate 2015-2020 (US$ Million)

    Figure 58. Asia Pacific Rivaroxaban Sales Market Share by Region in 2019

    Figure 59. Asia Pacific Rivaroxaban Revenue Market Share by Region in 2019

    Figure 60. China Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 61. China Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 62. Japan Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 63. Japan Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 64. South Korea Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 65. South Korea Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 66. India Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 67. India Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 68. Australia Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 69. Australia Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 70. Taiwan Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 71. Taiwan Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 72. Indonesia Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 73. Indonesia Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 74. Thailand Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 75. Thailand Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 76. Malaysia Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 77. Malaysia Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 78. Philippines Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 79. Philippines Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 80. Vietnam Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 81. Vietnam Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 82. Asia Pacific Rivaroxaban Market Share by Type in 2019

    Figure 83. Asia Pacific Rivaroxaban Market Share by Application in 2019

    Figure 84. Latin America Rivaroxaban Sales Growth Rate 2015-2020 (M Units)

    Figure 85. Latin America Rivaroxaban Revenue Growth Rate 2015-2020 (US$ Million)

    Figure 86. Latin America Rivaroxaban Sales Market Share by Country in 2019

    Figure 87. Latin America Rivaroxaban Revenue Market Share by Country in 2019

    Figure 88. Mexico Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 89. Mexico Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 90. Brazil Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 91. Brazil Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 92. Argentina Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 93. Argentina Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 94. Latin America Rivaroxaban Market Share by Type in 2019

    Figure 95. Latin America Rivaroxaban Market Share by Application in 2019

    Figure 96. Middle East and Africa Rivaroxaban Sales Growth Rate 2015-2020 (M Units)

    Figure 97. Middle East and Africa Rivaroxaban Revenue Growth Rate 2015-2020 (US$ Million)

    Figure 98. Middle East and Africa Rivaroxaban Sales Market Share by Country in 2019

    Figure 99. Middle East and Africa Rivaroxaban Revenue Market Share by Country in 2019

    Figure 100. Turkey Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 101. Turkey Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 102. Saudi Arabia Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 103. Saudi Arabia Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 104. UAE Rivaroxaban Sales Growth Rate (2015-2020) (M Units)

    Figure 105. UAE Rivaroxaban Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 106. Middle East and Africa Rivaroxaban Market Share by Type in 2019

    Figure 107. Middle East and Africa Rivaroxaban Market Share by Application in 2019

    Figure 108. Bayer Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 109. J&J Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 110. North America Rivaroxaban Sales Growth Rate Forecast (2021-2026) (M Units)

    Figure 111. North America Rivaroxaban Revenue Growth Rate Forecast (2021-2026) (US$ Million)

    Figure 112. Europe Rivaroxaban Sales Growth Rate Forecast (2021-2026) (M Units)

    Figure 113. Europe Rivaroxaban Revenue Growth Rate Forecast (2021-2026) (US$ Million)

    Figure 114. Asia Pacific Rivaroxaban Sales Growth Rate Forecast (2021-2026) (M Units)

    Figure 115. Asia Pacific Rivaroxaban Revenue Growth Rate Forecast (2021-2026) (US$ Million)

    Figure 116. Latin America Rivaroxaban Sales Growth Rate Forecast (2021-2026) (M Units)

    Figure 117. Latin America Rivaroxaban Revenue Growth Rate Forecast (2021-2026) (US$ Million)

    Figure 118. Middle East and Africa Rivaroxaban Sales Growth Rate Forecast (2021-2026) (M Units)

    Figure 119. Middle East and Africa Rivaroxaban Revenue Growth Rate Forecast (2021-2026) (US$ Million)

    Figure 120. Porter's Five Forces Analysis

    Figure 121. Channels of Distribution

    Figure 122. Distributors Profiles

    Figure 123. Bottom-up and Top-down Approaches for This Report

    Figure 124. Data Triangulation

    Figure 125. Key Executives Interviewed